Emergent Biosolutions (EBS): Congress and insider trades
Who in Congress and inside the company traded EBS, when each filing appeared, and what buying after each one would have earned against the S&P 500.
Key Facts
- Emergent Biosolutions (EBS) is a listed stock on NYSE.
- 2 members of Congress filed 2 buys and 3 sells of EBS, the latest published 2021-12-14 (14 December 2021).
- Insiders filed 0 open market buys worth $0 and 6 sells worth $577K, the latest filed 2026-07-02 (2 July 2026).
- Across 1 scored buy, Congress averaged +14.0% against the S&P 500 (SPY) over the 90 days after disclosure, with 100% of them ahead of the index. That result is too few trades to tell.
- Data as of 2026-09-29 (29 September 2026).
Congress trades in EBS
as of 2021-12-14| Filed | Member | Type | Size | Days to file | 90 day vs S&P |
|---|---|---|---|---|---|
| 14 Dec 2021 | Josh Gottheimer (D-NJ) | sell | 1K–15K | 38 | n/a |
| 16 Nov 2021 | Josh Gottheimer (D-NJ) | buy | 1K–15K | 28 | +14.0% |
| 14 Oct 2021 | Josh Gottheimer (D-NJ) | sell | 1K–15K | 28 | n/a |
| 11 Mar 2021 | Josh Gottheimer (D-NJ) | sell | 1K–15K | 15 | n/a |
| 16 Dec 2020 | Gil Cisneros (D-CA) | buy | 1K–15K | 21 | n/a |
Nothing matches that search.
Insider trades in EBS
as of 2026-07-02| Filed | Insider | Type | Shares | Price | Value | 90 day vs S&P |
|---|---|---|---|---|---|---|
| 2 Jul 2026 | Williams Paul Anthony | sell | 3,000 | $8.40 | $25.2K | n/a |
| 4 May 2026 | Dayal Sujata Tyagi | sell | 13,761 | $8.40 | $116K | n/a |
| 4 May 2026 | DeGolyer Donald W | sell | 15,481 | $8.40 | $130K | n/a |
| 4 May 2026 | Katkin Keith | sell | 15,481 | $8.28 | $128K | n/a |
| 4 May 2026 | Zoon Kathryn C | sell | 17,202 | $8.40 | $144K | n/a |
| 3 Apr 2026 | Williams Paul Anthony | sell | 4,000 | $8.44 | $33.8K | n/a |
Nothing matches that search.
Related pages
Frequently asked questions
Who has bought EBS?
2 Congress buys by 2 members and 0 insider buys are on file. The tables on this page list every one.
Did buying EBS after a disclosure beat the market?
Across 1 scored buy, Congress averaged +14.0% against the S&P 500 (SPY) over the 90 days after disclosure, with 100% of them ahead of the index. That result is too few trades to tell. A single stock is a small sample.
Sources: Congressional trades: STOCK Act disclosures, collected from CapitolTrades. Insider trades: SEC Form 4 filings, collected from Finviz. Prices: Yahoo Finance daily adjusted closes. Data as of 2026-09-29 (29 September 2026). About these sources.
Not investment advice. Past disclosed trades do not predict future returns. Disclosures are published late, so the trades shown are ones you could only have copied after the fact. Talk to a licensed adviser before you invest.